Login Register Cart 0
Current Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

COVID-19-associated Coagulopathy: Role of Vitamins D and K

Author(s): Bruk Getachew, Harold E. Landis, Kebreten F. Manaye and Yousef Tizabi*

Volume 24, Issue 3, 2023

Published on: 26 August, 2022

Page: [401 - 410] Pages: 10

DOI: 10.2174/1389201023666220527110455

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Recent reports show coagulopathy as a potential complication and poorer outcome of coronavirus disease 2019 (COVID-19), especially in those with comorbid conditions such as diabetes and hypertension as thrombosis could result in stroke and heart attacks. Indeed, cardiovascular complications in COVID-19 account for 40% of mortality. Although there is no standard treatment protocol or guidelines for COVID-19, it is a common practice to use anti-inflammatory corticosteroids and anti-coagulants, especially for severe COVID-19 patients. It has also been confirmed that deficiencies of vitamin D and/or vitamin K can exacerbate premorbid cardiovascular and diabetes conditions associated with COVID-19, at least partially due to a higher incidence of coagulopathy. Here, we discuss the roles of vitamins D and K in general and in COVID-19-related coagulopathy. Moreover, the suggestion for proper supplementations of these vitamins in countering COVID-19 is provided.

Keywords: Thrombosis, phylloquinone, menaquinone, vitamin D, SARS-CoV-2, COVID-19.

« Previous Next »

Graphical Abstract

Graphical abstract illustrating key findings of the study

[1]
Cui, S.; Chen, S.; Li, X.; Liu, S.; Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost., 2020, 18(6), 1421-1424.
[http://dx.doi.org/10.1111/jth.14830] [PMID: 32271988]
[2]
Tang, N.; Bai, H.; Chen, X.; Gong, J.; Li, D.; Sun, Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost., 2020, 18(5), 1094-1099.
[http://dx.doi.org/10.1111/jth.14817] [PMID: 32220112]
[3]
Oxley, T.J.; Mocco, J.; Majidi, S.; Kellner, C.P.; Shoirah, H.; Singh, I.P.; De Leacy, R.A.; Shigematsu, T. Large-vessel stroke as a presenting feature of covid-19 in the young. N. Engl. J. Med., 2020, 382(20), e60.
[4]
Bangalore, S.; Sharma, A.; Slotwiner, A.; Yatskar, L.; Harari, R.; Shah, B.; Ibrahim, H.; Friedman, G.H.; Thompson, C.; Alviar, C.L.; Chadow, H.L.; Fishman, G.I.; Reynolds, H.R.; Keller, N.; Hochman, J.S. ST-segment elevation in patients with covid-19 - A case series. N. Engl. J. Med., 2020, 382(25), 2478-2480.
[http://dx.doi.org/10.1056/NEJMc2009020] [PMID: 32302081]
[5]
Lodigiani, C.; Iapichino, G.; Carenzo, L.; Cecconi, M.; Ferrazzi, P.; Sebastian, T.; Kucher, N.; Studt, J.D.; Sacco, C.; Bertuzzi, A.; Sandri, M.T.; Barco, S. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res., 2020, 191, 9-14.
[http://dx.doi.org/10.1016/j.thromres.2020.04.024] [PMID: 32353746]
[6]
Luo, W.; Yu, H.; Gou, J.; Li, X.; Sun, Y.; Li, J.; Liu, L. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). 2020Preprints, , 2020020407.
[7]
Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA, 2020, 323(13), 1239-1242.
[http://dx.doi.org/10.1001/jama.2020.2648] [PMID: 32091533]
[8]
Janssen, R.; Visser, M.P.J.; Dofferhoff, A.S.M.; Vermeer, C.; Janssens, W.; Walk, J. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in coronavirus disease 2019. Br. J. Nutr., 2021, 126(2), 191-198.
[http://dx.doi.org/10.1017/S0007114520003979] [PMID: 33023681]
[9]
Sanyaolu, A.; Okorie, C.; Marinkovic, A.; Patidar, R.; Younis, K.; Desai, P.; Hosein, Z.; Padda, I.; Mangat, J.; Altaf, M. Comorbidity and its impact on patients with COVID-19. SN Compr. Clin. Med., 2020, 2(8), 1069-1076.
[http://dx.doi.org/10.1007/s42399-020-00363-4] [PMID: 32838147]
[10]
Liu, K.; Chen, Y.; Lin, R.; Han, K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J. Infect., 2020, 80(6), e14-e18.
[http://dx.doi.org/10.1016/j.jinf.2020.03.005] [PMID: 32171866]
[11]
Kang, S.J.; Jung, S.I. Age-related morbidity and mortality among patients with COVID-19. Infect. Chemother., 2020, 52(2), 154-164.
[http://dx.doi.org/10.3947/ic.2020.52.2.154] [PMID: 32537961]
[12]
Richardson, S.; Hirsch, J.S.; Narasimhan, M.; Crawford, J.M.; McGinn, T.; Davidson, K.W.; Barnaby, D.P.; Becker, L.B.; Chelico, J.D.; Cohen, S.L.; Cookingham, J.; Coppa, K.; Diefenbach, M.A.; Dominello, A.J.; Duer-Hefele, J.; Falzon, L.; Gitlin, J.; Hajizadeh, N.; Harvin, T.G.; Hirschwerk, D.A.; Kim, E.J.; Kozel, Z.M.; Marrast, L.M.; Mogavero, J.N.; Osorio, G.A.; Qiu, M.; Zanos, T.P. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new york city area. JAMA, 2020, 323(20), 2052-2059.
[http://dx.doi.org/10.1001/jama.2020.6775] [PMID: 32320003]
[13]
Visser, C.; Biedermann, J.S.; Nierman, M.C.; van der Meer, F.J.M.; Gulpen, A.J.W.; Moors, Y.C.F.; Cannegieter, S.C.; Lijfering, W.M.; Kruip, M.J.H.A. The immediate effect of COVID-19 vaccination on anticoagulation control in patients using vitamin K antagonists. Thromb. Haemost., 2022, 122(3), 377-385.
[http://dx.doi.org/10.1055/s-0042-1742628] [PMID: 35245945]
[14]
Becker, R.C. COVID-19 update: Covid-19-associated coagulopathy. J. Thromb. Thrombolysis, 2020, 50(1), 54-67.
[http://dx.doi.org/10.1007/s11239-020-02134-3] [PMID: 32415579]
[15]
Gómez-Mesa, J.E.; Galindo-Coral, S.; Montes, M.C.; Muñoz Martin, A.J. Thrombosis and coagulopathy in COVID-19. Curr. Probl. Cardiol., 2021, 46(3), 100742.
[http://dx.doi.org/10.1016/j.cpcardiol.2020.100742] [PMID: 33243440]
[16]
Wang, T.; Chen, R.; Liu, C.; Liang, W.; Guan, W.; Tang, R.; Tang, C.; Zhang, N.; Zhong, N.; Li, S. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol., 2020, 7(5), e362-e363.
[http://dx.doi.org/10.1016/S2352-3026(20)30109-5] [PMID: 32278361]
[17]
Lips, P.; Cashman, K.D.; Lamberg-Allardt, C.; Bischoff-Ferrari, H.A.; Obermayer-Pietsch, B.; Bianchi, M.L.; Stepan, J.; El-Hajj Fuleihan, G.; Bouillon, R. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: A position statement of the European Calcified Tissue Society. Eur. J. Endocrinol., 2019, 180(4), 23-P54.
[http://dx.doi.org/10.1530/EJE-18-0736] [PMID: 30721133]
[18]
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 2020, 395(10223), 507-513.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[19]
Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.; Wang, H.; Wang, Y.; Zhou, Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis., 2020, 94, 91-95.
[http://dx.doi.org/10.1016/j.ijid.2020.03.017] [PMID: 32173574]
[20]
Pivonello, R.; Auriemma, R.S.; Pivonello, C.; Isidori, A.M.; Corona, G.; Colao, A.; Millar, R.P. Sex disparities in COVID-19 severity and outcome: are men weaker or women stronger? Neuroendocrinology, 2021, 111(11), 1066-1085.
[http://dx.doi.org/10.1159/000513346] [PMID: 33242856]
[21]
Holcomb, D.; Alexaki, A.; Hernandez, N.; Hunt, R.; Laurie, K.; Kames, J.; Hamasaki-Katagiri, N.; Komar, A.A.; DiCuccio, M.; Kimchi-Sarfaty, C. Gene variants of coagulation related proteins that interact with SARS-CoV-2. PLOS Comput. Biol., 2021, 17(3), e1008805.
[http://dx.doi.org/10.1371/journal.pcbi.1008805] [PMID: 33730015]
[22]
Marfella, R.; Paolisso, P.; Sardu, C.; Bergamaschi, L.; D’Angelo, E.C.; Barbieri, M.; Rizzo, M.R.; Messina, V.; Maggi, P.; Coppola, N.; Pizzi, C.; Biffi, M.; Viale, P.; Galié, N.; Paolisso, G. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab., 2020, 46(5), 403-405.
[http://dx.doi.org/10.1016/j.diabet.2020.05.005] [PMID: 32447102]
[23]
Sagnelli, C.; Gentile, V.; Tirri, R.; Macera, M.; Cappabianca, S.; Ciccia, F.; Coppola, N. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient. J. Infect., 2020, 81(6), 979-997.
[http://dx.doi.org/10.1016/j.jinf.2020.05.043] [PMID: 32474034]
[24]
Abidi, E.; El Nekidy, W.S.; Alefishat, E.; Rahman, N.; Petroianu, G.A.; El-Lababidi, R.; Mallat, J. Tocilizumab and COVID-19: timing of administration and efficacy. Front. Pharmacol., 2022, 13, 825749.
[http://dx.doi.org/10.3389/fphar.2022.825749] [PMID: 35250575]
[25]
Gozzo, L.; Viale, P.; Longo, L.; Vitale, D.C.; Drago, F. The potential role of heparin in patients With COVID-19: beyond the anticoagulant effect. a review. Front. Pharmacol., 2020, 11, 1307.
[http://dx.doi.org/10.3389/fphar.2020.01307] [PMID: 32973526]
[26]
Grant, W.B.; Lahore, H.; McDonnell, S.L.; Baggerly, C.A.; French, C.B.; Aliano, J.L.; Bhattoa, H.P. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, 2020, 12(4), 988.
[http://dx.doi.org/10.3390/nu12040988] [PMID: 32252338]
[27]
Dofferhoff, A.S.M.; Piscaer, I.; Schurgers, L.J.; Visser, M.P.J.; van den Ouweland, J.M.W.; de Jong, P.A.; Gosens, R.; Hackeng, T.M.; van Daal, H.; Lux, P.; Maassen, C.; Karssemeijer, E.G.A.; Vermeer, C.; Wouters, E.F.M.; Kistemaker, L.E.M.; Walk, J.; Janssen, R. Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019. Clin. Infect. Dis., 2021, 73(11), e4039-e4046.
[http://dx.doi.org/10.1093/cid/ciaa1258] [PMID: 32852539]
[28]
Andrukhova, O.; Slavic, S.; Zeitz, U.; Riesen, S.C.; Heppelmann, M.S.; Ambrisko, T.D.; Markovic, M.; Kuebler, W.M.; Erben, R.G. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol. Endocrinol., 2014, 28(1), 53-64.
[http://dx.doi.org/10.1210/me.2013-1252] [PMID: 24284821]
[29]
Rahajeng Nurseta, T.; Rahardjo, B.; Irwanto, Y.; Suseno, D.A. Effect of vitamin D on elastin and collagen expression: In-vitro study of pelvic organ prolaps prevention. Eur. J. Med. Sci., 2021, 3(1), 37-41.
[30]
Hastie, C.E.; Mackay, D.F.; Ho, F.; Celis-Morales, C.A.; Katikireddi, S.V.; Niedzwiedz, C.L.; Jani, B.D.; Welsh, P.; Mair, F.S.; Gray, S.R.; O’Donnell, C.A.; Gill, J.M.; Sattar, N.; Pell, J.P. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab. Syndr., 2020, 14(4), 561-565.
[http://dx.doi.org/10.1016/j.dsx.2020.04.050] [PMID: 32413819]
[31]
Meltzer, D.O.; Best, T.J.; Zhang, H.; Vokes, T.; Arora, V.; Solway, J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw. Open, 2020, 3(9), e2019722.
[http://dx.doi.org/10.1001/jamanetworkopen.2020.19722] [PMID: 32880651]
[32]
D’Avolio, A.; Avataneo, V.; Manca, A.; Cusato, J.; De Nicolò, A.; Lucchini, R.; Keller, F.; Cantù, M. 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients, 2020, 12(5), 1359.
[http://dx.doi.org/10.3390/nu12051359] [PMID: 32397511]
[33]
Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; Guan, L.; Wei, Y.; Li, H.; Wu, X.; Xu, J.; Tu, S.; Zhang, Y.; Chen, H.; Cao, B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet, 2020, 395(10229), 1054-1062 Erratum in. Lancet, 2020, 395(10229), 1038.
[http://dx.doi.org/10.1016/S0140-6736(20)30566-3] [PMID: 32171076]
[34]
Levi, M.; Thachil, J.; Iba, T.; Levy, J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol., 2020, 7(6), e438-e440.
[http://dx.doi.org/10.1016/S2352-3026(20)30145-9] [PMID: 32407672]
[35]
Schmitt, F.C.F.; Manolov, V.; Morgenstern, J.; Fleming, T.; Heitmeier, S.; Uhle, F.; Al-Saeedi, M.; Hackert, T.; Bruckner, T.; Schöchl, H.; Weigand, M.A.; Hofer, S.; Brenner, T. Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: Results of an observational pilot study. Ann. Intensive Care, 2019, 9(1), 19.
[http://dx.doi.org/10.1186/s13613-019-0499-6] [PMID: 30701381]
[36]
Kudelko, M.; Yip, T.F.; Hei Law, G.C.; Lee, S.M.Y. Hei, Law, G.C., Lee, S.M.Y. Potential beneficial effects of vitamin K in SARS-CoV-2 induced vascular disease? Immuno., 2021, 1(1), 17-29.
[http://dx.doi.org/10.3390/immuno1010003]
[37]
Esmon, C.T.; Vigano-D’Angelo, S.; D’Angelo, A.; Comp, P.C. Anticoagulation proteins C and S. Adv. Exp. Med. Biol., 1987, 214, 47-54.
[PMID: 2959034]
[38]
Tabatabai, A.; Rabin, J.; Menaker, J.; Madathil, R.; Galvagno, S.; Menne, A.; Chow, J.H.; Grazioli, A.; Herr, D.; Tanaka, K.; Scalea, T.; Mazzeffi, M. Factor VIII and functional protein C activity in critically Ill patients with coronavirus disease 2019: A case series. A A Pract., 2020, 14(7), e01236.
[http://dx.doi.org/10.1213/XAA.0000000000001236] [PMID: 32539272]
[39]
Qin, C.; Zhou, L.; Hu, Z.; Zhang, S.; Yang, S.; Tao, Y.; Xie, C.; Ma, K.; Shang, K.; Wang, W.; Tian, D.S. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis., 2020, 71(15), 762-768.
[http://dx.doi.org/10.1093/cid/ciaa248] [PMID: 32161940]
[40]
Gupta, N.; Zhao, Y.Y.; Evans, C.E. The stimulation of thrombosis by hypoxia. Thromb. Res., 2019, 181, 77-83.
[http://dx.doi.org/10.1016/j.thromres.2019.07.013] [PMID: 31376606]
[41]
Hoff, E.; Zou, D.; Schiza, S.; Demir, Y.; Grote, L.; Bouloukaki, I.; Beydemir, Ş.; Eskandari, D.; Stenlöf, K.; Hedner, J. Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention. J. Sleep Res., 2020, 29(2), e12956.
[http://dx.doi.org/10.1111/jsr.12956] [PMID: 31808986]
[42]
Bompard, F.; Monnier, H.; Saab, I.; Tordjman, M.; Abdoul, H.; Fournier, L.; Sanchez, O.; Lorut, C.; Chassagnon, G.; Revel, M.P. Pulmonary embolism in patients with COVID-19 pneumonia. Eur. Respir. J., 2020, 56(1), 2001365.
[http://dx.doi.org/10.1183/13993003.01365-2020] [PMID: 32398297]
[43]
https://www.escardio.org/Education/COVID-19-and-Cardiology/ESCCOVID-19-Guidance2022
[44]
Young, E. The anti-inflammatory effects of heparin and related compounds. Thromb. Res., 2008, 122(6), 743-752.
[http://dx.doi.org/10.1016/j.thromres.2006.10.026] [PMID: 17727922]
[45]
Tavassoly, O.; Safavi, F.; Tavassoly, I. Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection. Mol. Pharmacol., 2020, 98(5), 612-619.
[http://dx.doi.org/10.1124/molpharm.120.000098] [PMID: 32913137]
[46]
Shi, C.; Tingting, W.; Li, J.P.; Sullivan, M.A.; Wang, C.; Wang, H.; Deng, B.; Zhang, Y. Comprehensive landscape of heparin therapy for COVID-19. Carbohydr. Polym., 2021, 254, 117232.
[http://dx.doi.org/10.1016/j.carbpol.2020.117232] [PMID: 33357843]
[47]
Giordo, R.; Zinellu, A.; Eid, A.H.; Pintus, G. Therapeutic potential of Resveratrol in COVID-19-associated hemostatic disorders. Molecules, 2021, 26(4), 856.
[http://dx.doi.org/10.3390/molecules26040856] [PMID: 33562030]
[48]
Holick, M.F. Vitamin D deficiency in 2010: Health benefits of vitamin D and sunlight: A D-bate. Nat. Rev. Endocrinol., 2011, 7(2), 73-75.
[http://dx.doi.org/10.1038/nrendo.2010.234] [PMID: 21263437]
[49]
Salamanna, F.; Maglio, M.; Sartori, M.; Landini, M.P.; Fini, M. Vitamin D and platelets: A menacing duo in COVID-19 and potential rela-tion to bone remodeling. Int. J. Mol. Sci., 2021, 22(18), 10010.
[http://dx.doi.org/10.3390/ijms221810010] [PMID: 34576172]
[50]
Tangpricha, V.; Pearce, E.N.; Chen, T.C.; Holick, M.F. Vitamin D insufficiency among free-living healthy young adults. Am. J. Med., 2002, 112(8), 659-662.
[http://dx.doi.org/10.1016/S0002-9343(02)01091-4] [PMID: 12034416]
[51]
Sassi, F.; Tamone, C.; D’Amelio, P.; Vitamin, D.; Vitamin, D. Nutrient, hormone, and immunomodulator. Nutrients, 2018, 10(11), 1656.
[http://dx.doi.org/10.3390/nu10111656] [PMID: 30400332]
[52]
Shakoor, H.; Feehan, J.; Al Dhaheri, A.S.; Ali, H.I.; Platat, C.; Ismail, L.C.; Apostolopoulos, V.; Stojanovska, L. Immuneboosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas, 2021, 143, 1-9.
[http://dx.doi.org/10.1016/j.maturitas.2020.08.003] [PMID: 33308613]
[53]
Zhang, J.; McCullough, P.A.; Tecson, K.M. Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19. Rev. Cardiovasc. Med., 2020, 21(3), 339-344.
[http://dx.doi.org/10.31083/j.rcm.2020.03.131] [PMID: 33070539]
[54]
Koyama, T.; Shibakura, M.; Ohsawa, M.; Kamiyama, R.; Hirosawa, S. Anticoagulant effects of 1alpha, 25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Blood, 1998, 92(1), 160-167.
[http://dx.doi.org/10.1182/blood.V92.1.160.413k16_160_167] [PMID: 9639512]
[55]
Beer, T.M.; Venner, P.M.; Ryan, C.W.; Petrylak, D.P.; Chatta, G.; Dean Ruether, J.; Chi, K.N.; Curd, J.G.; DeLoughery, T.G. High dose calcitriol may reduce thrombosis in cancer patients. Br. J. Haematol., 2006, 135(3), 392-394.
[http://dx.doi.org/10.1111/j.1365-2141.2006.06322.x] [PMID: 16984385]
[56]
García-Carrasco, M.; Jiménez-Herrera, E.A.; Gálvez-Romero, J.L.; Mendoza-Pinto, C.; Méndez-Martínez, S.; Etchegaray-Morales, I. Munguía-Realpozo, P.; Vázquez de Lara-Cisneros, L.; Santa Cruz, F.J.; Cervera, R. The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome. Lupus, 2018, 27(14), 2181-2189.
[http://dx.doi.org/10.1177/0961203318801520] [PMID: 30282560]
[57]
Tripkovic, L.; Lambert, H.; Hart, K.; Smith, C.P.; Bucca, G.; Penson, S.; Chope, G.; Hyppönen, E.; Berry, J.; Vieth, R.; Lanham-New, S. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis. Am. J. Clin. Nutr., 2012, 95(6), 1357-1364.
[http://dx.doi.org/10.3945/ajcn.111.031070] [PMID: 22552031]
[58]
Makris, K.; Sempos, C.; Cavalier, E. The measurement of vitamin D metabolites: Part I-metabolism of vitamin D and the measurement of 25-hydroxyvitamin D. Hormones , 2020, 19(2), 81-96.
[http://dx.doi.org/10.1007/s42000-019-00169-7] [PMID: 31919677]
[59]
Xiao, L.; Xing, C.; Yang, Z.; Xu, S.; Wang, M.; Du, H.; Liu, K.; Huang, Z. Vitamin D supplementation for the prevention of childhood acute respiratory infections: A systematic review of randomised controlled trials. Br. J. Nutr., 2015, 114(7), 1026-1034.
[http://dx.doi.org/10.1017/S000711451500207X] [PMID: 26310436]
[60]
Martineau, A.R.; Jolliffe, D.A.; Hooper, R.L.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Ginde, A.A.; Goodall, E.C.; Grant, C.C.; Griffiths, C.J.; Janssens, W.; Laaksi, I.; Manaseki-Holland, S.; Mauger, D.; Murdoch, D.R.; Neale, R.; Rees, J.R.; Simpson, S., Jr; Stelmach, I.; Kumar, G.T.; Urashima, M.; Camargo, C.A. Jr Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ, 2017, 356, i6583.
[http://dx.doi.org/10.1136/bmj.i6583] [PMID: 28202713]
[61]
Zisi, D.; Challa, A.; Makis, A. The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood. Hormones , 2019, 18(4), 353-363.
[http://dx.doi.org/10.1007/s42000-019-00155-z] [PMID: 31768940]
[62]
Jolliffe, D.A.; Camargo, C.A.; Sluyter, J.D.; Aglipay, M.; Aloia, J.F.; Ganmaa, D. Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol., 2021, 9(5), 276-292.
[http://dx.doi.org/10.1101/2020.07.14.20152728]
[63]
Aglipay, M.; Birken, C.S.; Parkin, P.C.; Loeb, M.B.; Thorpe, K.; Chen, Y.; Laupacis, A.; Mamdani, M.; Macarthur, C.; Hoch, J.S.; Maz-zulli, T.; Maguire, J.L. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA, 2017, 318(3), 245-254.
[http://dx.doi.org/10.1001/jama.2017.8708] [PMID: 28719693]
[64]
Janssens, W.; Decramer, M.; Mathieu, C.; Korf, H. Vitamin D and chronic obstructive pulmonary disease: Hype or reality? Lancet Respir. Med., 2013, 1(10), 804-812.
[http://dx.doi.org/10.1016/S2213-2600(13)70102-4] [PMID: 24461760]
[65]
Song, Y.; Qi, H.; Wu, C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology, 2007, 12(4), 486-494.
[http://dx.doi.org/10.1111/j.1440-1843.2007.01099.x] [PMID: 17587413]
[66]
Heulens, N.; Korf, H.; Cielen, N.; De Smidt, E.; Maes, K.; Gysemans, C.; Verbeken, E.; Gayan-Ramirez, G.; Mathieu, C.; Janssens, W. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice. Respir. Res., 2015, 16(1), 110.
[http://dx.doi.org/10.1186/s12931-015-0271-x] [PMID: 26376849]
[67]
Allegra, A.; Tonacci, A.; Pioggia, G.; Musolino, C.; Gangemi, S. Vitamin deficiency as risk factor for SARS-CoV-2 infection: Correlation with susceptibility and prognosis. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(18), 9721-9738.
[PMID: 33015818]
[68]
Brito, D.T.M.; Ribeiro, L.H.C.; Daltro, C.H.D.C.; Silva, R.B. The possible benefits of vitamin D in COVID-19. Nutrition, 2021, 91-92, 111356.
[http://dx.doi.org/10.1016/j.nut.2021.111356] [PMID: 34352586]
[69]
Charoenngam, N.; Shirvani, A.; Holick, M.F. Vitamin D and Its Potential Benefit for the COVID-19 Pandemic. Endocr. Pract., 2021, 27(5), 484-493.
[http://dx.doi.org/10.1016/j.eprac.2021.03.006] [PMID: 33744444]
[70]
Getachew, B.; Tizabi, Y. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity. J. Med. Virol., 2021, 93(9), 5285-5294.
[http://dx.doi.org/10.1002/jmv.27075] [PMID: 33990955]
[71]
Maha, Q.; Talal, M. Can Vitamin D deficiency increase the susceptibility to COVID-19? Front. Physiol., 2021, 12, 630956.
[http://dx.doi.org/10.3389/fphys.2021.630956] [PMID: 34093219]
[72]
Walsh, J.B.; McCartney, D.M.; Laird, É.; McCarroll, K.; Byrne, D.G.; Healy, M.; O’Shea, P.M.; Kenny, R.A.; Faul, J.L. Title: Understanding a low vitamin D state in the context of COVID-19. Front. Pharmacol., 2022, 13, 835480.
[http://dx.doi.org/10.3389/fphar.2022.835480] [PMID: 35308241]
[73]
Holick, M.F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev. Endocr. Metab. Disord., 2017, 18(2), 153-165.
[http://dx.doi.org/10.1007/s11154-017-9424-1] [PMID: 28516265]
[74]
Rubin, R. Sorting out whether vitamin D deficiency raises COVID-19 risk. JAMA, 2021, 325(4), 329-330.
[http://dx.doi.org/10.1001/jama.2020.24127]
[75]
Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr., 2004, 80(6)(Suppl.), 1678S-1688S.
[http://dx.doi.org/10.1093/ajcn/80.6.1678S] [PMID: 15585788]
[76]
Melamed, M.L.; Michos, E.D.; Post, W.; Astor, B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med., 2008, 168(15), 1629-1637.
[http://dx.doi.org/10.1001/archinte.168.15.1629] [PMID: 18695076]
[77]
Dancer, R.C.; Parekh, D.; Lax, S.; D’Souza, V.; Zheng, S.; Bassford, C.R.; Park, D.; Bartis, D.G.; Mahida, R.; Turner, A.M.; Sapey, E.; Wei, W.; Naidu, B.; Stewart, P.M.; Fraser, W.D.; Christopher, K.B.; Cooper, M.S.; Gao, F.; Sansom, D.M.; Martineau, A.R.; Perkins, G.D.; Thickett, D.R. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax, 2015, 70(7), 617-624.
[http://dx.doi.org/10.1136/thoraxjnl-2014-206680] [PMID: 25903964]
[78]
Marik, P.E.; Kory, P.; Varon, J. Does vitamin D status impact mortality from SARS-CoV-2 infection? Med. Drug Discov., 2020, 6, 100041.
[http://dx.doi.org/10.1016/j.medidd.2020.100041] [PMID: 32352080]
[79]
McCartney, D.M.; Byrne, D.G. Optimisation of vitamin D status for enhanced Immuno-protection against Covid-19. Ir. Med. J., 2020, 113(4), 58.
[PMID: 32268051]
[80]
Ceolin, G.; Mano, G.P.R.; Hames, N.S.; Antunes, L.D.C.; Brietzke, E.; Rieger, D.K.; Moreira, J.D.; Vitamin, D.; Vitamin, D. Depressive Symptoms, and Covid-19 Pandemic. Front. Neurosci., 2021, 15, 670879.
[http://dx.doi.org/10.3389/fnins.2021.670879] [PMID: 34054418]
[81]
Panarese, A.; Shahini, E. Letter: Covid-19, and vitamin D. Aliment. Pharmacol. Ther., 2020, 51(10), 993-995.
[http://dx.doi.org/10.1111/apt.15752] [PMID: 32281109]
[82]
Mitchell, F. Vitamin-D and COVID-19: Do deficient risk a poorer outcome? Lancet Diabetes Endocrinol., 2020, 8(7), 570.
[http://dx.doi.org/10.1016/S2213-8587(20)30183-2] [PMID: 32445630]
[83]
Cantorna, M.T.; Snyder, L.; Lin, Y.D.; Yang, L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients, 2015, 7(4), 3011-3021.
[http://dx.doi.org/10.3390/nu7043011] [PMID: 25912039]
[84]
Khademvatani, K.; Seyyed-Mohammadzad, M.H.; Akbari, M.; Rezaei, Y.; Eskandari, R.; Rostamzadeh, A. The relationship between vitamin D status and idiopathic lower-extremity deep vein thrombosis. Int. J. Gen. Med., 2014, 7, 303-309.
[PMID: 24971035]
[85]
Wu, W.X.; He, D.R. Low vitamin D levels are associated with the development of deep venous thromboembolic events in patients with ischemic stroke. Clin. Appl. Thromb. Hemost, 2018, 24(9_suppl)(Suppl.), 69S-75S.
[http://dx.doi.org/ 10.1177/1076029618786574] [PMID: 30033760]
[86]
Blondon, M.; Biver, E.; Braillard, O.; Righini, M.; Fontana, P.; Casini, A. Thrombin generation and fibrin clot structure after vitamin D supplementation. Endocr. Connect., 2019, 8(11), 1447-1454.
[http://dx.doi.org/10.1530/EC-19-0429] [PMID: 31614338]
[87]
Lindqvist, P.G.; Epstein, E.; Olsson, H. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis. J. Thromb. Haemost., 2009, 7(4), 605-610.
[http://dx.doi.org/10.1111/j.1538-7836.2009.03312.x] [PMID: 19335448]
[88]
Hejazi, M.E.; Modarresi-Ghazani, F.; Hamishehkar, H.; Mesgari-Abbasi, M.; Dousti, S.; Entezari-Maleki, T. The effect of treatment of vitamin d deficiency on the level of P-selectin and hs-CRP in patients with thromboembolism: A pilot randomized clinical trial. J. Clin. Pharmacol., 2017, 57(1), 40-47.
[http://dx.doi.org/10.1002/jcph.774] [PMID: 27225617]
[89]
Ohsawa, M.; Koyama, T.; Yamamoto, K.; Hirosawa, S.; Kamei, S.; Kamiyama, R. 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation, 2000, 102(23), 2867-2872.
[http://dx.doi.org/10.1161/01.CIR.102.23.2867] [PMID: 11104746]
[90]
Aihara, K.; Azuma, H.; Akaike, M.; Ikeda, Y.; Yamashita, M.; Sudo, T.; Hayashi, H.; Yamada, Y.; Endoh, F.; Fujimura, M.; Yoshida, T.; Yamaguchi, H.; Hashizume, S.; Kato, M.; Yoshimura, K.; Yamamoto, Y.; Kato, S.; Matsumoto, T. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J. Biol. Chem., 2004, 279(34), 35798-35802.
[http://dx.doi.org/10.1074/jbc.M404865200] [PMID: 15205460]
[91]
Wu-wong, J. R.; Nakane, M.; Ma, J. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin- 1 and thrombomodulin in human aortic smooth muscle cells. J. Va.s Res. 2007, 44(1), 11-18.
[92]
Martinez-Moreno, J.M.; Herencia, C.; Montes de Oca, A.; Muñoz-Castañeda, J.R.; Rodríguez-Ortiz, M.E.; Díaz-Tocados, J.M.; Peralbo-Santaella, E.; Camargo, A.; Canalejo, A.; Rodriguez, M.; Velasco-Gimena, F.; Almaden, Y. Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells. FASEB J., 2016, 30(3), 1367-1376.
[http://dx.doi.org/10.1096/fj.15-272872] [PMID: 26700731]
[93]
Topaloglu, O.; Arslan, M.S.; Karakose, M.; Ucan, B.; Ginis, Z.; Cakir, E.; Akkaymak, E.T.; Sahin, M.; Ozbek, M.; Cakal, E.; Delibasi, T. Is there any association between thrombosis and tissue factor pathway inhibitor levels in patients with vitamin D deficiency? Clin. Appl. Thromb. Hemost., 2015, 21(5), 428-433.
[http://dx.doi.org/10.1177/1076029613509477] [PMID: 24203351]
[94]
Svenungsson, E.; Antovic, A. The antiphospholipid syndrome - often overlooked cause of vascular occlusions? J. Intern. Med., 2020, 287(4), 349-372.
[http://dx.doi.org/10.1111/joim.13022] [PMID: 31957081]
[95]
Sengupta, T.; Majumder, R.; Majumder, S. Role of vitamin D in treating COVID-19-associated coagulopathy: Problems and perspectives. Mol. Cell. Biochem., 2021, 476(6), 2421-2427.
[http://dx.doi.org/10.1007/s11010-021-04093-6] [PMID: 33604809]
[96]
Teymoori-Rad, M.; Marashi, S.M. Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions. Rev. Med. Virol., 2021, 31(2), e2159.
[PMID: 32856339]
[97]
Annweiler, C.; Beaudenon, M.; Gautier, J.; Simon, R.; Dubée, V.; Gonsard, J.; Parot-Schinkel, E. COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): Study protocol for a randomized controlled trial. Trials, 2020, 21(1), 1031.
[http://dx.doi.org/10.1186/s13063-020-04928-5] [PMID: 33371905]
[98]
Ling, S.F.; Broad, E.; Murphy, R.; Pappachan, J.M.; Pardesi-Newton, S.; Kong, M.F.; Jude, E.B. High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: A cross-sectional multi-centre observational study. Nutrients, 2020, 12(12), 3799.
[http://dx.doi.org/10.3390/nu12123799] [PMID: 33322317]
[99]
van Ballegooijen, A.J.; Beulens, J.W.J.; Schurgers, L.J.; de Koning, E.J.; Lips, P.; van Schoor, N.M.; Vervloet, M.G. Effect of 6-month vitamin D supplementation on plasma matrix Gla protein in older adults. Nutrients, 2019, 11(2), 231.
[http://dx.doi.org/10.3390/nu11020231] [PMID: 30678199]
[100]
Harshman, S.G.; Shea, M.K. The role of Vitamin K in chronic aging diseases: inflammation, cardiovascular disease, and osteoarthritis. Curr. Nutr. Rep., 2016, 5(2), 90-98.
[http://dx.doi.org/10.1007/s13668-016-0162-x] [PMID: 27648390]
[101]
Simes, D.C.; Viegas, C.S.B.; Araújo, N.; Marreiros, C. Vitamin K as a powerful micronutrient in aging and age-related diseases: Pros and cons from clinical studies. Int. J. Mol. Sci., 2019, 20(17), 4150.
[102]
Akbulut, A.C.; Pavlic, A.; Petsophonsakul, P.; Halder, M.; Maresz, K.; Kramann, R.; Schurgers, L. Vitamin K2 needs an RDI separate from vitamin K1. Nutrients, 2020, 12(6), 1852.
[http://dx.doi.org/10.3390/nu12061852] [PMID: 32575901]
[103]
Demir, Y. Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases. Drug Dev. Res., 2020, 81(5), 628-636.
[http://dx.doi.org/10.1002/ddr.21667] [PMID: 32232985]
[104]
Marles, R.J.; Roe, A.L.; Oketch-Rabah, H.A. US Pharmacopeial Convention safety evaluation of menaquinone-7, a form of vitamin K. Nutr. Rev., 2017, 75(7), 553-578.
[http://dx.doi.org/10.1093/nutrit/nux022] [PMID: 28838081]
[105]
Schurgers, L.J.; Teunissen, K.J.; Hamulyák, K.; Knapen, M.H.; Vik, H.; Vermeer, C. Vitamin K-containing dietary supplements: Compari-son of synthetic vitamin K1 and natto-derived menaquinone-7. Blood, 2007, 109(8), 3279-3283.
[http://dx.doi.org/10.1182/blood-2006-08-040709] [PMID: 17158229]
[106]
Vitamin and Mineral Requirements in Human Nutrition; World Health Organization: Geneva, Switzerland, 2004.
[107]
Binkley, N.C.; Krueger, D.C.; Engelke, J.A.; Foley, A.L.; Suttie, J.W. Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. Am. J. Clin. Nutr., 2000, 72(6), 1523-1528.
[http://dx.doi.org/10.1093/ajcn/72.6.1523] [PMID: 11101481]
[108]
Shearer, M.J.; Mallinson, C.N.; Webster, G.R.; Barkhan, P. Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K 1 in man. Br. J. Haematol., 1972, 22(5), 579-588.
[http://dx.doi.org/10.1111/j.1365-2141.1972.tb05704.x] [PMID: 5032096]
[109]
Schurgers, L.J.; Vermeer, C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta, 2002, 1570(1), 27-32.
[http://dx.doi.org/10.1016/S0304-4165(02)00147-2] [PMID: 11960685]
[110]
Spronk, H.M.; Soute, B.A.; Schurgers, L.J.; Thijssen, H.H.; De Mey, J.G.; Vermeer, C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarintreated rats. J. Vasc. Res., 2003, 40(6), 531-537.
[http://dx.doi.org/10.1159/000075344] [PMID: 14654717]
[111]
Halder, M.; Petsophonsakul, P.; Akbulut, A.C.; Pavlic, A.; Bohan, F.; Anderson, E.; Maresz, K.; Kramann, R.; Schurgers, L.; Vitamin, K.; Vitamin, K. Double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease. Int. J. Mol. Sci., 2019, 20(4), 896.
[http://dx.doi.org/10.3390/ijms20040896] [PMID: 30791399]
[112]
Kaneki, M.; Hodges, S.J.; Hosoi, T.; Fujiwara, S.; Lyons, A.; Crean, S.J.; Ishida, N.; Nakagawa, M.; Takechi, M.; Sano, Y.; Mizuno, Y.; Hoshino, S.; Miyao, M.; Inoue, S.; Horiki, K.; Shiraki, M.; Ouchi, Y.; Orimo, H. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk. Nutrition, 2001, 17(4), 315-321.
[http://dx.doi.org/10.1016/S0899-9007(00)00554-2] [PMID: 11369171]
[113]
Dahlberg, S.; Schurgers, L.; Schött, U.; Kander, T. Vitamin K deficiency in critical ill patients; a prospective observational study. J. Crit. Care, 2019, 49, 105-109.
[http://dx.doi.org/10.1016/j.jcrc.2018.10.022] [PMID: 30415179]
[114]
Suleiman, L.; Négrier, C.; Boukerche, H.; Protein, S. A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit. Rev. Oncol. Hematol., 2013, 88(3), 637-654.
[http://dx.doi.org/10.1016/j.critrevonc.2013.07.004] [PMID: 23958677]
[115]
Anastasi, E.; Ialongo, C.; Labriola, R.; Ferraguti, G.; Lucarelli, M.; Angeloni, A. Vitamin K deficiency and covid-19. Scand. J. Clin. Lab. Invest., 2020, 80(7), 525-527.
[http://dx.doi.org/10.1080/00365513.2020.1805122] [PMID: 32779537]
[116]
Hardy, M.; Lecompte, T.; Douxfils, J.; Lessire, S.; Dogné, J.M.; Chatelain, B.; Testa, S.; Gouin-Thibault, I.; Gruel, Y.; Medcalf, R.L.; Ten Cate, H.; Lippi, G.; Mullier, F. Management of the thrombotic risk associated with COVID-19: Guidance for the hemostasis laboratory. Thromb. J., 2020, 18(1), 17.
[http://dx.doi.org/10.1186/s12959-020-00230-1] [PMID: 32922211]
[117]
Umeda, H.; Aikawa, M.; Libby, P. Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases. Biochem. Biophys. Res. Commun., 2011, 411(2), 281-286.
[http://dx.doi.org/10.1016/j.bbrc.2011.06.124] [PMID: 21726534]
[118]
Shioi, A.; Morioka, T.; Shoji, T.; Emoto, M. The inhibitory roles of vitamin K in progression of vascular calcification. Nutrients, 2020, 12(2), 583.
[http://dx.doi.org/10.3390/nu12020583] [PMID: 32102248]
[119]
Iba, T.; Levy, J.H. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology, 2020, 132(5), 1238-1245.
[http://dx.doi.org/10.1097/ALN.0000000000003122] [PMID: 32044801]
[120]
McCann, J.C.; Ames, B.N. Vitamin K, an example of triage theory: Is micronutrient inadequacy linked to diseases of aging? Am. J. Clin. Nutr., 2009, 90(4), 889-907.
[http://dx.doi.org/10.3945/ajcn.2009.27930] [PMID: 19692494]
[121]
Azoulay, L.; Dell’Aniello, S.; Simon, T.A.; Renoux, C.; Suissa, S. Initiation of warfarin in patients with atrial fibrillation: Early effects on ischaemic strokes. Eur. Heart J., 2014, 35(28), 1881-1887.
[http://dx.doi.org/10.1093/eurheartj/eht499] [PMID: 24353282]
[122]
Alperin, J.B. Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. JAMA, 1987, 258(14), 1916-1919.
[http://dx.doi.org/10.1001/jama.1987.03400140078028] [PMID: 3656602]
[123]
Manna, P.; Kalita, J. Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review. Rev. Nutr., 2016, 32(7-8), 732-739.
[http://dx.doi.org/10.1016/j.nut.2016.01.011] [PMID: 27133809]
[124]
Campbell, A.W. Vitamin K2 in the prevention of cardiovascular diseases and diabetes. Altern. Ther. Health Med., 2017, 23(2), 8-10.
[PMID: 28323623]
[125]
van Ballegooijen, A.J.; Cepelis, A.; Visser, M.; Brouwer, I.A.; van Schoor, N.M.; Beulens, J.W. Joint association of low vitamin D and vitamin K status with blood pressure and hypertension. Hypertension, 2017, 69(6), 1165-1172.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.08869] [PMID: 28396533]
[126]
Linneberg, A.; Kampmann, F.B.; Israelsen, S.B.; Andersen, L.R.; Jørgensen, H.L.; Sandholt, H.; Jørgensen, N.R.; Thysen, S.M.; Benfield, T. The association of low vitamin K status with mortality in a cohort of 138 hospitalized patients with COVID-19. Nutrients, 2021, 13(6), 1985.
[http://dx.doi.org/10.3390/nu13061985] [PMID: 34207745]
[127]
Asakura, H.; Ogawa, H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol., 2021, 113(1), 45-57.
[http://dx.doi.org/10.1007/s12185-020-03029-y] [PMID: 33161508]
[128]
Popa, D.S.; Bigman, G.; Rusu, M.E. The role of vitamin K in humans: Implication in aging and age-associated diseases. Antioxidants, 2021, 10(4), 566.
[http://dx.doi.org/10.3390/antiox10040566] [PMID: 33917442]
[129]
Bjørklund, G.; Svanberg, E.; Dadar, M.; Card, D.J.; Chirumbolo, S.; Harrington, D.J.; Aaseth, J. The role of Matrix Gla Protein (MGP) in vascular calcification. Curr. Med. Chem., 2020, 27(10), 1647-1660.
[http://dx.doi.org/10.2174/0929867325666180716104159] [PMID: 30009696]
[130]
van Ballegooijen, A.J.; Beulens, J.W.J.; Keyzer, C.A.; Navis, G.J.; Berger, S.P.; de Borst, M.H.; Vervloet, M.G.; Bakker, S.J.L. Joint associ-ation of vitamins D and K status with long-term outcomes in stable kidney transplant recipients. Nephrol. Dial. Transplant., 2020, 35(4), 706-714.
[http://dx.doi.org/10.1093/ndt/gfy399] [PMID: 30753729]
[131]
Desai, A.P.; Dirajlal-Fargo, S.; Durieux, J.C.; Tribout, H.; Labbato, D.; McComsey, G.A.; Vitamin, K. D deficiencies are independently associated with COVID-19 disease severity. Open Forum Infect. Dis., 2021, 8(10), ofab408.
[http://dx.doi.org/10.1093/ofid/ofab408]
[132]
Kumar, P.; Kumar, M.; Bedi, O.; Gupta, M.; Kumar, S.; Jaiswal, G.; Rahi, V.; Yedke, N.G.; Bijalwan, A.; Sharma, S.; Jamwal, S. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology, 2021, 29(4), 1001-1016.
[http://dx.doi.org/10.1007/s10787-021-00826-7] [PMID: 34110533]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 48
Html icon 2
Find your institution